Cytomegalovirus resistance in CD34 -selected hematopoietic cell transplant recipients. (Q52640678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

title

Cytomegalovirus resistance in CD34 -selected hematopoietic cell transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

Genovefa Anna Papanicolaou

21 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

6

Sergio A Giralt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Seong Jin Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

Yao-Ting Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

Julia Foldi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

Molly Maloy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

Ann A Jakubowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

publication date

10 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

e12881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

21 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Cytomegalovirus Infection after CD34( )-Selected Hematopoietic Cell Transplantation

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Approach to drug-resistant cytomegalovirus in transplant recipients

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Cytomegalovirus-specific T-cell therapies: current status and future prospects

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Monitoring of cytomegalovirus viral loads by two molecular assays in whole-blood and plasma samples from hematopoietic stem cell transplant recipients

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

The biology of cytomegalovirus drug resistance

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Antiviral Drug Resistance of Human Cytomegalovirus

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

How we treat cytomegalovirus in hematopoietic cell transplant recipients

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5988949

New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results

7 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29570237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29570237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29570237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/TID.12881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29570237 AND SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

29570237

1 reference